نتایج جستجو برای: functional pituitary adenomas

تعداد نتایج: 631995  

2014
Anna Kopczak Ulrich Renner Günter Karl Stalla

Pituitary tumors are common in the general population. Since neuroimaging techniques have improved, pituitary tumors are more often diagnosed incidentally. About 16.7% of the general population show changes in the pituitary gland. Predominantly, pituitary tumors are benign pituitary adenomas. Pituitary carcinomas or aggressive pituitary tumors are extremely rare. They might develop from benign ...

2016
Branavan Manoranjan Sujeivan Mahendram Saleh A. Almenawer Chitra Venugopal Nicole McFarlane Robin Hallett Thusyanth Vijayakumar Almunder Algird Naresh K. Murty Doron D. Sommer John P. Provias Kesava Reddy Sheila K. Singh

Classified as benign central nervous system (CNS) tumors, pituitary adenomas account for 10% of diagnosed intracranial neoplasms. Although surgery is often curative, patients with invasive macroadenomas continue to experience significant morbidity and are prone to tumor recurrence. Given the identification of human brain tumor-initiating cells (TICs) that initiate and maintain tumor growth whil...

Journal: :Journal of Neurology, Neurosurgery & Psychiatry 1997

2015
Cristiana Tanase Radu Albulescu Elena Codrici Bogdan Calenic Ionela Daniela Popescu Simona Mihai Laura Necula Maria Linda Cruceru Mihail Eugen Hinescu

PURPOSE Apoptotic protease-activating factor-1 (APAF-1) and cathepsin B are important functional proteins in apoptosis; the former is involved in the intrinsic (mitochondrial) pathway, while the latter is associated with both intrinsic and extrinsic pathways. Changes in the expression of apoptosome-related proteins could be useful indicators of tumor development since a priori defects in the mi...

Journal: :مجله دانشکده پزشکی دانشگاه علوم پزشکی تهران 0
سیدعلی فخر طباطبائی sa fakhr tabatabai هوشنگ صابری h saberi

to improve visual disturbance, optic nerve decompression can be performed via transcranial or tran-sphenoidal approaches. although the surgical exposure in transcranial approach is favourable, yet the optic nerve's presence in the field may make it vulnerable to damage. of fighty patients with different types of pituitary adenomas, 35 cases with medium-sized (1-3 cm) tumors have been studi...

Journal: :Journal of cellular physiology 2007
Arianna Bottoni Maria Chiara Zatelli Manuela Ferracin Federico Tagliati Daniela Piccin Cristina Vignali George A Calin Massimo Negrini Carlo M Croce Ettore C Degli Uberti

MicroRNAs (miRNAs) are small non-coding RNAs that control gene expression by targeting mRNA. It has been demonstrated that miRNA expression is altered in many human cancers, suggesting that they may play a role in human neoplasia. To determine whether miRNA expression is altered in pituitary adenomas, we analyzed the entire miRNAome in 32 pituitary adenomas and in 6 normal pituitary samples by ...

Journal: :Endocrine-related cancer 2007
A Raitila M Georgitsi A Karhu K Tuppurainen M J Mäkinen K Birkenkamp-Demtröder K Salmenkivi T F Orntoft J Arola V Launonen P Vahteristo L A Aaltonen

Germline mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene were recently observed in patients with pituitary adenoma predisposition (PAP). Though AIP mutation-positive individuals with prolactin-, mixed growth hormone/prolactin-, and ACTH-producing pituitary adenomas as well as non-secreting pituitary adenomas have been reported, most mutation-positive patients have had ...

Journal: :Endokrynologia Polska 2010
Marek Pawlikowski Jolanta Kunert-Radek Maciej Radek

INTRODUCTION Plurihormonality of pituitary adenomas can be defined as the ability of an adenoma to express more than one pituitary hormone. The application of immunohistochemistry to diagnose surgically removed pituitary tumours revealed that a great number of pituitary adenomas are in fact plurihormonal. However, data on the incidence and the clinical relevance of the pituitary adenoma pluriho...

2017
Alejandro Ibáñez-Costa Laura M. López-Sánchez Manuel D. Gahete Esther Rivero-Cortés Mari C. Vázquez-Borrego María A. Gálvez Andrés de la Riva Eva Venegas-Moreno Luis Jiménez-Reina Alberto Moreno-Carazo Francisco J. Tinahones Silvia Maraver-Selfa Miguel A. Japón Juan A. García-Arnés Alfonso Soto-Moreno Susan M. Webb Rhonda D. Kineman Michael D. Culler Justo P. Castaño Raúl M. Luque

Chimeric somatostatin/dopamine compounds such as BIM-23A760, an sst2/sst5/D2 receptors-agonist, have emerged as promising new approaches to treat pituitary adenomas. However, information on direct in vitro effects of BIM-23A760 in normal and tumoral pituitaries remains incomplete. The objective of this study was to analyze BIM-23A760 effects on functional parameters (Ca2+ signaling, hormone exp...

2012
Subramanian Kannan Susan M. Staugaitis Robert J. Weil Betul Hatipoglu

Pituitary adenomas can express and secrete different hormones. Expression of pituitary hormones in nonneoplastic pituitary cells is regulated by different transcription factors. Some pituitary adenomas show plurihormonal expression. The most commonly reported plurihormonal adenomas are composed of somatotrophs, lactotrophs, thyrotrophs and gonadotrophs. Pituitary adenomas composed of both corti...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید